Biotech, Food, Drug

The National Law Review includes articles impacting the biotechnology, food, and drug industries. In the biotechnology realm, we examine many issues with a cross-over in intellectual property, such as licensing and patenting, intellectual property due diligence, litigation and tax. We also feature content on nanotechnology, biosimilars, greenhouse gas (GHG) regulation, biofuels and, biologics. Analysis includes actions by government entities such as the Food and Drug Administration (FDA), Food Safety and Inspection Service (FSIS), and United States Department of Agriculture (USDA). Common issues address by these agencies and in the industry include various food and beverage regulation, drug pricing and rebates, medical devices, country-of-origin labeling, nutrition labeling, and use of medical and recreational marijuana.

Date	Title	Organization
21 Jul	DOJ and OIG Announce Largest Ever National Health Care Fraud Takedown; Focus on Opioids	Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
21 Jul	Ninth Circuit Denies Motion for Further Mandamus Relief in Chlorpyrifos Proceedings	Bergeson & Campbell, P.C.
21 Jul	DOE Announces Up To $8 Million In Funding For Algae Biofuels Projects	Bergeson & Campbell, P.C.
21 Jul	FSMA Funds 2017: More Green for Greens	Keller and Heckman LLP
21 Jul	Are Zero Tolerance Drug Testing Policies About to Go Up in Smoke?	Epstein Becker & Green, P.C.
20 Jul	Will Employers Be Forced to Accommodate Employees Who Test Positive for Marijuana?	Jackson Lewis P.C.
20 Jul	Claim of Massachusetts Employee Fired for Medical Marijuana Use May Proceed, State High Court Rules	Jackson Lewis P.C.
20 Jul	Massachusetts: Medical Marijuana as Reasonable Accommodation in Workplace	Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
20 Jul	Food-Borne Illness Outbreaks: A Case Study	Keller and Heckman LLP
20 Jul	Understanding Bolar and Bolar-Like Exceptions in U.S. and Abroad – Part 1	Michael Best & Friedrich LLP